Inactive Instrument

Other languages DECHRA PHARMACEUTICALS LIMITED OTC Markets

Equities

Dechra Pharmaceuticals Limited Appoints Jonathan David Lang as Director	06-09
Dechra Pharmaceuticals Limited acquired 33.34% stake in STEM Animal Health Inc.	04-14
Dechra Group Holdings Limited Appoints Paul Nicholas Sandland as Director	04-09
Dechra Group Holdings Limited Appoints Ian David Page as Director	04-09
Dechra Group Holdings Limited Announces Resignation of Thomas Spicer as Director	04-09
Dechra Group Holdings Limited Announces Resignation of Anthony Santospirito as Director	04-09
Dechra Group Holdings Limited Announces Resignation of Sara Huda as Director	04-09
Stocks slump as Fed rate cut hope dwindles	01-17
Dechra Pharmaceuticals Delists From London Bourse Following Freya Bidco’s Takeover	01-17
EQT's Freya Bidco Completes Dechra Pharmaceuticals Purchase	01-16
EQT X EUR SCSp and EQT X USD SCSp managed by Eqt Fund Management S.à R.L. and Luxinva SA (the Offerors) completed the acquisition of Dechra Pharmaceuticals PLC.	01-15
BOLETÍN MATINAL : 12 de enero de 2024	01-12
Persimmon to replace outbound FTSE 100 constituent Dechra	01-12
EU clears Dechra Pharmaceuticals takeover by EQT funds	12-27
EQT's Dechra Takeover to Become Effective in Mid-January 2024	12-27
EQT's Takeover of Dechra Pharmaceuticals Gets EU Antitrust Regulator's Nod	12-22
Inchcape to appoint Jerry Buhlmann to chair board of directors from May	12-14
Pharma und Gesundheit: weitere Konsolidierung	12-13
Farma en gezondheid: consolidatie gaat door	12-12
Farmaceutica e salute: continua il consolidamento	12-11

No results for this search